Birdwatch Note
2023-12-04 09:41:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この0.85%の話はファイザーワクチンの臨床試験の有効性は相対リスクだと95%減少(プラセボ162人→ワクチン8人）だが絶対リスクだと解析者約18000人の参加者中154人(0.85%)しか減っていないという話です↓ https://www.reuters.com/article/factcheck-thelancet-riskreduction/fact-check-why-relative-risk-reduction-not-absolute-risk-reduction-is-most-often-used-in-calculating-vaccine-efficacy-idUSL2N2NK1XA/ ゆえに投稿者のブログ中の実は効果ない的なネット噂を肯定する物では一切ないです(プラセボでも1%もいないんだから最大でも1%以上の効果にはならないだけ) でプラセボも162人しか発症してないというのは「流行が下火の20年秋の試験中の中央値2か月間」の話で↓ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115787/ 米国は21年秋までに3分の1程が感染抗体を有し多数の国民が曝露されてます↓ https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm#F1_down
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1731599773218857451
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1731609567447159225
- noteId - 1731609567447159225
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1701682867287
- tweetId - 1731599773218857451
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この0.85%の話はファイザーワクチンの臨床試験の有効性は相対リスクだと95%減少(プラセボ162人→ワクチン8人）だが絶対リスクだと解析者約18000人の参加者中154人(0.85%)しか減っていないという話です↓ https://www.reuters.com/article/factcheck-thelancet-riskreduction/fact-check-why-relative-risk-reduction-not-absolute-risk-reduction-is-most-often-used-in-calculating-vaccine-efficacy-idUSL2N2NK1XA/ ゆえに投稿者のブログ中の実は効果ない的なネット噂を肯定する物では一切ないです(プラセボでも1%もいないんだから最大でも1%以上の効果にはならないだけ) でプラセボも162人しか発症してないというのは「流行が下火の20年秋の試験中の中央値2か月間」の話で↓ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115787/ 米国は21年秋までに3分の1程が感染抗体を有し多数の国民が曝露されてます↓ https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm#F1_down
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-12-04 09:41:07 UTC (1701682867287) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-05 03:33:02 UTC (1701747182239) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-12-04 17:39:28 -0600 | Rating Details | |
| 2023-12-04 15:40:37 -0600 | Rating Details | |
| 2023-12-04 13:44:33 -0600 | Rating Details | |
| 2023-12-04 10:13:23 -0600 | Rating Details | |
| 2023-12-04 09:38:39 -0600 | Rating Details | |
| 2023-12-04 09:25:16 -0600 | Rating Details | |
| 2023-12-04 09:01:21 -0600 | Rating Details | |
| 2023-12-04 08:13:52 -0600 | Rating Details | |
| 2023-12-04 07:44:00 -0600 | Rating Details | |
| 2023-12-04 06:52:32 -0600 | Rating Details | |
| 2023-12-04 06:30:21 -0600 | Rating Details | |
| 2023-12-04 06:07:39 -0600 | Rating Details | |
| 2023-12-04 05:48:19 -0600 | Rating Details | |
| 2023-12-04 05:46:38 -0600 | Rating Details | |
| 2023-12-04 05:30:37 -0600 | Rating Details | |
| 2023-12-04 05:00:58 -0600 | Rating Details | |
| 2023-12-04 04:58:01 -0600 | Rating Details | |
| 2023-12-04 04:49:40 -0600 | Rating Details | |
| 2023-12-04 04:41:55 -0600 | Rating Details | |
| 2023-12-04 04:41:01 -0600 | Rating Details | |
| 2023-12-04 04:28:37 -0600 | Rating Details | |
| 2023-12-04 04:19:53 -0600 | Rating Details | |
| 2023-12-04 04:01:17 -0600 | Rating Details | |
| 2023-12-05 04:39:24 -0600 | Rating Details | |
| 2023-12-05 03:17:25 -0600 | Rating Details | |
| 2023-12-05 02:31:10 -0600 | Rating Details | |
| 2023-12-05 01:57:06 -0600 | Rating Details | |
| 2023-12-05 00:35:54 -0600 | Rating Details | |
| 2023-12-04 22:33:14 -0600 | Rating Details | |
| 2023-12-04 19:11:04 -0600 | Rating Details | |
| 2023-12-05 18:51:19 -0600 | Rating Details | |
| 2023-12-04 22:29:42 -0600 | Rating Details | |
| 2023-12-04 10:57:19 -0600 | Rating Details | |
| 2023-12-04 08:24:51 -0600 | Rating Details | |
| 2023-12-04 06:16:58 -0600 | Rating Details | |
| 2023-12-04 04:42:58 -0600 | Rating Details | |
| 2023-12-04 04:36:06 -0600 | Rating Details | |
| 2023-12-04 03:57:55 -0600 | Rating Details | |
| 2023-12-07 13:13:59 -0600 | Rating Details |